Mit Patel has taken on a significant leadership role as Senior QA Manager at Amneal Pharmaceuticals, continuing his impressive journey in the pharmaceutical formulation industry. With over a decade of experience in quality assurance, compliance, and system development, Mit brings a wealth of operational expertise and strategic oversight to this position. He has been associated with Amneal for more than nine years, steadily progressing through a variety of impactful roles that highlight his deep understanding of end-to-end quality systems.
Currently based in India, Mit leads a wide spectrum of functions, including Quality Management Systems (QMS), Audit and Regulatory Compliance, In-process Quality Assurance (IPQA), Lab QA, Training Systems, and Documentation. His responsibilities span not just implementation but also ensuring that the QA framework aligns with global standards, making him a key figure in maintaining Amneal’s product quality and regulatory readiness.
Throughout his tenure at Amneal, Mit has consistently demonstrated his strength in managing cross-functional teams and improving process efficiencies. From his early days as QA Executive to Assistant Manager and then QA Manager, he has led major initiatives involving deviation management, CAPA implementation, document control, and training frameworks—all vital to sustaining regulatory compliance and audit preparedness.
Before joining Amneal, Mit honed his QA skills across renowned organizations such as Cipla, Famy Care Ltd., Zydus BSV Pharma, and Unimark Remedies Ltd. His responsibilities ranged from validation and qualification to handling internal audits and QMS compliance, laying the groundwork for the leadership he now demonstrates at Amneal.
With his deep-rooted expertise and a leadership style that focuses on team building and continuous improvement, Mit Patel is well-positioned to steer Amneal’s quality operations toward further excellence. His elevation to Senior QA Manager signals the company’s continued commitment to ensuring the highest levels of product integrity and compliance across its global pharmaceutical footprint.